|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 405/12 | |
| A61K 31/404 | |||
| A61P 11/00 |
| (11) | Patento numeris | 2563778 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11713134.2 |
| Europos patento paraiškos padavimo data | 2011-03-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-03-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/030032 |
| Data | 2011-03-25 |
| (87) | Numeris | WO 2011/119984 |
| Data | 2011-09-29 |
| (30) | Numeris | Data | Šalis |
| 321636 P | 2010-04-07 | US | |
| 321561 P | 2010-04-07 | US | |
| 319953 P | 2010-04-01 | US | |
| 317376 P | 2010-03-25 | US |
| (72) |
KESHAVARZ-SHOKRI, Ali, US
ZHANG, Beili, US
ALCACIO, Tim, Edward, US
LEE, Elaine, Chungmin, US
ZHANG, Yuegang, US
KRAWIEC, Mariusz, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (54) | CRYSTALLINE FORM OF (R)-1(2,2 -DIFLUOROBENZO[D][1,3]DIOXOL-5YL)-N-(1-(2,3-DIHYDEROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2YL)-1H-INDOL-5YL)CYCLOPROPANECARBOXAMIDE |
| CRYSTALLINE FORM OF (R)-1(2,2 -DIFLUOROBENZO[D][1,3]DIOXOL-5YL)-N-(1-(2,3-DIHYDEROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2YL)-1H-INDOL-5YL)CYCLOPROPANECARBOXAMIDE |